info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Paroxysmal Atrial Tachycardia Companies

Paroxysmal atrial tachycardia is a type of supraventricular tachycardia characterized by rapid heartbeats originating above the heart's ventricles. Companies in the medical device industry may develop and manufacture devices related to the diagnosis, monitoring, or treatment of paroxysmal atrial tachycardia. 

Paroxysmal Atrial Tachycardia Key Companies

 

Latest Paroxysmal Atrial Tachycardia Companies Update


Abbott (US) Received FDA approval for their AmpliPhiâ„¢ HD Grid Catheter for ablation of complex arrhythmias including PAT, offering precise mapping and ablation capabilities.Partnered with leading electrophysiologists to develop next-generation ablation technologies with real-time image guidance and AI-powered algorithms.


Boston Scientific (US) Launched their TactiCath â„¢ Contact Force Sensing Catheter for ablation procedures, providing real-time pressure feedback to optimize safety and effectiveness during PAT treatment.Collaborated with research institutions to explore the potential of robotic-assisted ablation systems for enhanced precision and control in treating arrhythmias.


Biosense Webster (US) Introduced their Cartoâ„¢ 3 System with CARTOFINDERâ„¢ technology, enabling rapid and accurate localization of arrhythmia sources for efficient PAT ablation.Announced a strategic partnership with Medtronic to develop integrated solutions for advanced arrhythmia management and ablation procedures.


St. Jude Medical (US) Received CE Mark approval for their EnSiteâ„¢ NavX System with X2 technology, offering enhanced 3D mapping and navigation functionalities for complex arrhythmia ablation including PAT.Focused on developing innovative ablation catheters with steerable tips and irrigation features for improved access and treatment efficacy.


Acteon (France) Introduced their CARTO® Sound Navigation System, utilizing acoustic markers to guide catheter placement during ablation procedures, providing an alternative to fluoroscopy and minimizing radiation exposure.Partnered with healthcare providers in Asia Pacific to expand access to their advanced ablation technologies for treating PAT and other arrhythmias.


List of Paroxysmal Atrial Tachycardia Key Companies in the Market



  • Abbott Laboratories

  • Reliant Pharmaceuticals

  • BIOTRONIK SE & Co. KG

  • Boston Scientific Corporation

  • GlaxoSmithKline plc

  • GE Healthcare

  • Glenmark Pharmaceuticals

  • Koninklijke Philips N.V.

  • ANI Pharmaceuticals Inc.

  • Medtronic Inc.

  • Microport Scientific Corporation

  • Jude Medical Inc.

  • Siemens AG


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.